文献速递重症综合管理与镇静镇痛

丁丙诺啡在脓毒症小鼠模型中显著升高一组替代标志物

Buprenorphine Markedly Elevates a Panel of Surrogate Markers in a Murine Model of Sepsis.
PubMed 文献 · Shock · 2019-01-01
一句话结论作者强烈推荐:在观察较晚期(如CLP后24小时及以后)全身炎症与动物死亡的实验性脓毒症研究中,不要重复给予丁丙诺啡,以避免其对脓毒症动物模型的潜在干扰。

该研究在雄性C57BL/6小鼠中采用盲肠结扎穿孔(CLP)模拟脓毒症,按当地政府机构建议开展预试验,发现重复给予丁丙诺啡可使20%至60%的脓毒症动物循环中四种脓毒症替代标志物(IL-6、KC、单核细胞趋化蛋白-1、粒细胞集落刺激因子)水平显著升高。作者认为该并发症可能损害CLP模型可靠模拟人类脓毒症及研究致死性脓毒症发病机制的能力。作者强烈推荐在观察较晚期(如CLP后24小时及以后)全身炎症与动物死亡的实验性脓毒症研究中,不要重复给予丁丙诺啡。

要点

  • 在CLP脓毒症小鼠模型中,重复给予丁丙诺啡可使20%至60%的脓毒症动物循环中IL-6、KC、单核细胞趋化蛋白-1和粒细胞集落刺激因子水平显著升高。
  • 作者强烈推荐:在观察较晚期(如CLP后24小时及以后)全身炎症与动物死亡的实验性脓毒症研究中,不要重复给予丁丙诺啡。
  • 既往证据提示丁丙诺啡可显著升高雄性C57BL/6小鼠循环IL-6水平并降低动物存活率,但在雌性小鼠中未见此现象,可能与动情周期的复杂干扰有关。
  • 作者认为丁丙诺啡引起的替代标志物升高可能损害CLP模型可靠模拟人类脓毒症及研究致死性脓毒症发病机制的能力。

适用人群与场景

  • 雄性C57BL/6小鼠,采用盲肠结扎穿孔(CLP)手术模拟脓毒症。
  • 关注较晚期(如CLP后24小时及以后)全身炎症与动物死亡的实验性脓毒症研究。

处置流程与药物剂量

  • 作者强烈推荐:对于观察较晚期(如CLP后24小时及以后)全身炎症与动物死亡的实验性脓毒症研究,不要重复给予丁丙诺啡,以消除其对脓毒症动物模型的潜在并发症。

研究设计与关键结果

  • 研究类型为预试验(pilot study),在雄性C57BL/6小鼠CLP脓毒症模型中开展。
  • 重复给予丁丙诺啡后,20%至60%的脓毒症动物循环中四种脓毒症替代标志物(IL-6、KC、单核细胞趋化蛋白-1、粒细胞集落刺激因子)水平显著升高。
  • 既往证据显示丁丙诺啡可显著升高雄性C57BL/6小鼠循环IL-6水平并降低动物存活率,但在雌性小鼠中未见此现象,可能与动情周期的复杂干扰有关。

证据类型、等级与局限

  • 证据类型:动物实验预试验(pilot study),采用CLP脓毒症小鼠模型。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者强烈推荐:在观察较晚期(如CLP后24小时及以后)全身炎症与动物死亡的实验性脓毒症研究中,不要重复给予丁丙诺啡。
  • 作者认为重复给予丁丙诺啡所致的替代标志物升高可能损害CLP模型可靠模拟人类脓毒症及研究致死性脓毒症发病机制的能力。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Sepsis can be simulated in animals by perforating the cecum via a surgical procedure termed "cecal ligation and puncture" (CLP), which induces similar inflammatory responses as observed during the clinical course of human sepsis. In addition to anesthetic agents, many Institutional Animal Care and Use Committees often recommend the use of additional analgesic agents (such as opioid) to further augment the initial anesthetic effects. However, emerging evidence suggest that a commonly recommended opioid, buprenorphine, dramatically elevated circulating interleukin (IL)-6 levels, and reduced animal survival in male C57BL/6 mice, but not in female mice possibly due to the complex interference of estrous cycles, fueling an ongoing debate regarding the possible impact of analgesic administration on the sepsis-induced systemic inflammation. As per the recommendation of a local government agency, we performed a pilot study and confirmed that repetitive administration of buprenorphine indeed markedly elevated circulating levels of four sepsis surrogate markers (e.g., IL-6, KC, monocyte chemoattractant protein-1, and granulocyte-colony stimulating factor) in 20% to 60% of septic animals. This complication may adversely jeopardize our ability to use the CLP model to reliably simulate human sepsis, and to understand the complex mechanism underlying the pathogenesis of lethal sepsis. Thus, for experimental sepsis studies set to survey systemic inflammation and animal lethality at relatively later stages (e.g., at 24 h post CLP and beyond), we strongly recommend not to repetitively administer buprenorphine to eliminate its potential complication to animal sepsis models.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Chen W, Brenner M, Aziz M, et al. Buprenorphine Markedly Elevates a Panel of Surrogate Markers in a Murine Model of Sepsis. Shock. 2019. PMID: 31486774. doi:10.1097/SHK.0000000000001361

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。